PinkDx — The Gyne Cancer Company™ — is transforming the diagnostic journey in gynecologic cancer
PinkDx — The Gyne Cancer Company™ — is transforming the diagnostic journey in gynecologic cancer. We apply scientific discovery and integrate whole-transcriptome sequencing and machine learning to deliver evidence-based insights that guide clinical decisions, giving women and physicians the answers they deserve.